Decades of clinical research point to multiple improvements when GHK-Cu is used topically: 1
There is one absolute contraindication that every thyroid patient must know about
GLP-1 receptor agonists work by: Stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps regulate blood sugar levels Slowing gastric emptying , meaning food remains in the stomach longer, promoting feelings of fullness Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger signals and food cravings Decreasing glucagon secretion , which helps prevent excessive glucose production by the liver Most GLP-1 agonists are administered via subcutaneous injection, typically once weekly or once daily depending on the specific formulation, though oral semaglutide (Rybelsus) is also available
clinician/pharmacy oversight
it has a half-life of approximately 7 days, meaning the drug accumulates with each weekly injection
But the risk increases when taken with other diabetes medications that do